Understanding CAR-M Technology with Carisma Therapeutics' Dr. Debora Barton
Nov 24, 2021•19 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
We love to hear from our listeners. Send us a message.
Carisma Therapeutics’ Dr. Barton breaks down the latest in CAR-M technology as well as the company's Phase 1 First-in-Human Study of Adenovirally Transduced Anti-HER2 CAR Macrophages in Subjects with HER2 Overexpressing Solid Tumors.
For the best experience, listen in Metacast app for iOS or Android